Published On: September 10th, 2021Categories: News

BioLoomics is excited to welcome Dr. Bill Kohlbrenner to the team as Vice President of Business Development. Prior to joining BioLoomics, Bill has had a fruitful career in pharma and biotech in both scientific and business development. He was CEO at NeuroLucent, a start-up focused on Alzheimer’s. Bill is also CSO at Life Science Nation (LSN), which offers fund-raising services to early-stage companies. Prior to LSN, Bill was a Business Development executive at AbbVie where he led a global scouting team. He has also directed drug discovery
programs in oncology, antivirals and antibacterials.

At BioLoomics, Bill will help to launch our platform of assay development and drug discovery services, enabling other pharma companies to access the power of our ‘evolution in a microscope’ technology. We are delighted to welcome Bill to the team and to work together through the next phase of growth at BioLoomics.